Synlogic Inc (NAS:SYBX)
$ 1.72 -0.03 (-1.71%) Market Cap: 20.00 Mil Enterprise Value: -10.12 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 45/100

Synlogic Inc at Chardan Leadership Call Transcript

Jun 07, 2022 / 04:30PM GMT
Release Date Price: $16.2 (-0.46%)
Keay Thomas Nakae;Aoife M.
Chardan Capital Markets, LLC, Research Division - Senior Research Analyst of Therapeutics, Devices and Diagnostics

Thank you, everyone, for attending Chardan's leadership call with President and Chief Executive Officer of Synlogic Therapeutics, Dr. Aoife Brennan. My name is Keay Nakae, I'm one of the senior health care research analyst at Chardan, where our vision is to help identify companies with high potential for investment returns based on creating real value for society through disruptive innovation.

Before we get started, our compliance department has asked us to read this statement, our participant has a tested and agreed that they will not share or discuss any material, nonpublic or confidential information that they are aware of. A recording of this call will be made available to clients after the call. The format for this event is a 15-minute presentation followed by about 15 minutes of Q&A. (Operator Instructions).

So with that, Aoife, thank you so much for joining us today. Why don't you go ahead with your presentation?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot